Revance Therapeutics Inc (NASDAQ:RVNC)

12.68
Delayed Data
As of 4:00pm ET
 -0.47 / -3.57%
Today’s Change
12.34
Today|||52-Week Range
33.83
-22.30%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Rankin Aubrey
Sale7/26/202155,382$29.72$1.6M-55.64%
Rankin Aubrey
Sale7/28/202134,332$30.00$1.0M-56.20%
Foley Mark J
President & Chief Executive Officer
Sale10/13/202142,096$23.08$971.6K-42.94%
Rankin Aubrey
Sale2/01/202133,119$25.95$859.4K-50.08%
Rankin Aubrey
Sale3/04/202133,119$25.43$842.2K-48.77%
Rankin Aubrey
Sale7/28/202120,000$30.15$603.0K-56.20%
Foley Mark J
Chief Executive Officer
Buy11/29/202140,000$12.90$516.0K+5.70%
Rankin Aubrey
Buy12/03/202130,000$14.43$432.9K-9.79%
Rankin Aubrey
Sale8/16/20219,364$26.34$246.6K-50.38%
Rankin Aubrey
Sale8/15/20214,949$26.02$128.8K-50.38%
Page of 4